Voyageur Pharmaceuticals Ltd. (TSXV:VM)

Canada flag Canada · Delayed Price · Currency is CAD
0.1300
-0.0100 (-7.14%)
At close: Mar 20, 2026
Market Cap23.22M -3.5%
Revenue (ttm)11.04K
Net Income-3.13M
EPS-0.02
Shares Out178.59M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume26,600
Average Volume64,290
Open0.1350
Previous Close0.1400
Day's Range0.1300 - 0.1350
52-Week Range0.1250 - 0.3600
Beta0.16
RSI35.32
Earnings DateMar 27, 2026

About Voyageur Pharmaceuticals

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in acquiring, exploring, and developing raw materials for pharmaceutical products in the United States of America, the province of British Columbia, Canada, and the state of Utah. It develops barium and iodine-based APIs. The company offers Smooth HD, Smooth X, Smooth LD, Vision HD, Vision LD, V-Gas, and other products. The company has a collaboration with Bayer Aktiengesellschaft for the research and development of evaluating potential future production of iodine to be used... [Read more]

Sector Healthcare
CEO Brent Willis
Country Canada
Stock Exchange TSX Venture Exchange
Ticker Symbol VM
Full Company Profile

Financial Performance

Financial Statements